Genomic Analysis of Antimicrobial Resistance Genotype-to-Phenotype Agreement in Helicobacter pylori.

作者: Tal Domanovich-Asor , Yair Motro , Boris Khalfin , Hillary A. Craddock , Avi Peretz

DOI: 10.3390/MICROORGANISMS9010002

关键词:

摘要: Antimicrobial resistance (AMR) in Helicobacter pylori is increasing and can result treatment failure inappropriate antibiotic usage. This study used whole genome sequencing (WGS) to comprehensively analyze the H. resistome phylogeny order characterize Israeli pylori. isolates (n = 48) underwent antimicrobial susceptibility testing (AST) against five antimicrobials WGS analysis. Literature review identified 111 mutations reported correlate with phenotypic these antimicrobials. Analysis was conducted via our in-house bioinformatics pipeline targeting point relevant genes (pbp1A, 23S rRNA, gyrA, rdxA, frxA, rpoB) assess genotype-to-phenotype correlation. Resistance rates of were as follows: clarithromycin 54%, metronidazole 31%, amoxicillin 10%, rifampicin 4%, levofloxacin 2%. Genotype-to-phenotype correlation inconsistent; for every analyzed gene at least one phenotypically susceptible isolate found have a mutation previously associated resistance. also observed regarding commonly commercial kits diagnose AMR cases. Furthermore, 11 novel resistant phenotype detected. unique set demonstrates that inferring phenotypes from remains challenging should be optimized further.

参考文章(33)
Avi Peretz, Maya Paritsky, Eleonora Dinisman-Zavulunov, Nina Pastukh, Tatyana Glyatman, Avi On, Susceptibility of Helicobacter pylori to Levofloxacin and Rifampicin in Israel Microbial Drug Resistance. ,vol. 21, pp. 448- 451 ,(2015) , 10.1089/MDR.2014.0250
Leonardo H. Eusebi, Rocco M. Zagari, Franco Bazzoli, Epidemiology ofHelicobacter pyloriInfection Helicobacter. ,vol. 19, pp. 1- 5 ,(2014) , 10.1111/HEL.12165
Alba A. Trespalacios, William Otero, Jorge E. Caminos, Marcela M. Mercado, Jenny Ávila, Liliana E. Rosero, Azucena Arévalo, Raúl A. Poutou-Piñales, David Y. Graham, Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia. Journal of Microbiology. ,vol. 51, pp. 448- 452 ,(2013) , 10.1007/S12275-013-2465-6
Mārcis Leja, Anthony Axon, Hermann Brenner, Epidemiology of Helicobacter pylori Infection Helicobacter. ,vol. 9, pp. 1- 6 ,(2004) , 10.1111/HEL.12332
Avi Peretz, Maya Paritsky, Omar Nasser, Diana Brodsky, Tatyana Glyatman, Sofia Segal, Avi On, Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults. The Journal of Antibiotics. ,vol. 67, pp. 555- 557 ,(2014) , 10.1038/JA.2014.38
Noam Zevit, Itzhak Levy, Haim Shmuely, Zmira Samra, Jacob Yahav, Antibiotic resistance of Helicobacter pylori in Israeli children. Scandinavian Journal of Gastroenterology. ,vol. 45, pp. 550- 555 ,(2010) , 10.3109/00365521003663688
P. J. Jenks, R. L. Ferrero, A. Labigne, The role of the rdxA gene in the evolution of metronidazole resistance in Helicobacter pylori Journal of Antimicrobial Chemotherapy. ,vol. 43, pp. 753- 758 ,(1999) , 10.1093/JAC/43.6.753
Jyh-Ming Liou, Chi-Yang Chang, Wang-Huei Sheng, Yu-Chi Wang, Mei-Jyh Chen, Yi-Chia Lee, Hsu-Wei Hung, Hung Chian, San-Chun Chang, Ming-Shiang Wu, Jaw-Town Lin, Genotypic Resistance in Helicobacter pylori Strains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies Antimicrobial Agents and Chemotherapy. ,vol. 55, pp. 1123- 1129 ,(2011) , 10.1128/AAC.01131-10
V. De Francesco, A. Zullo, E. Ierardi, F. Giorgio, F. Perna, C. Hassan, S. Morini, C. Panella, D. Vaira, Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits Journal of Antimicrobial Chemotherapy. ,vol. 65, pp. 327- 332 ,(2010) , 10.1093/JAC/DKP445